Subscribe to RSS

DOI: 10.1055/s-0041-1736402
Accuracy of Magnetic Resonance Parkinsonism Index in Differentiating Progressive Supranuclear Palsy from Parkinson's Disease among South Indian Population: A Retrospective Case Control Study

Abstract
Context Progressive supranuclear palsy (PSP) is a neurodegenerative disorder which comes under Parkinsonism plus syndrome. As this spectrum of disease has many overlapping clinical as well as imaging findings, some quantitative parameters like magnetic resonance Parkinsonism index and midbrain/pons ratio are useful to differentiate PSP from other PD patients.
Aims The study aimed to detect sensitivity and specificity of magnetic resonance Parkinsonism index in differentiating PSP from PD.
Settings and Design It was a retrospective case–control study conducted in Sri Manankula Vinayagar Medical College, Puducherry, during the period of January 2018 to June 2019.
Materials and Methods The 87 subjects, who were diagnosed and grouped into three categories (PSP, PD, and control) after performing magnetic resonance imaging brain, were reviewed. The parameters like the area of Pons and midbrain, width of MCP and SCP, P/M, M/P, and MRPI were calculated.
Statistical Analysis One-way ANOVA and Chi-square test was used. The sensitivity, specificity, diagnostic accuracy, and cut-off values obtained with receiver operating characteristic curve analysis were determined.
Results The mean age of presentation was approximately 75 years with male predominance. The cut-off value of MRPI obtained in this study was 13.4 with 100% sensitivity and specificity. Even though M/P ratio was found to be statistically significant among PSP patients; cut-off value was not obtained.
Conclusion MRPI was concluded as the better tool in diagnosing PSP compared with the M/P ratio. Hence the combined qualitative as well as quantitative measurement of MRPI will increase the diagnostic accuracy of PSP.
Keywords
magnetic resonance Parkinsonism index - midbrain/pons ratio - progressive supranuclear palsy - Parkinson's diseaseFinancial Support and Sponsorship
None.
Publication History
Article published online:
13 November 2021
© 2021. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Quattrone A, Morelli M, Williams DR. et al. MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism. Neurology 2016; 87 (12) 1266-1273
- 2 Quattrone A, Nicoletti G, Messina D. et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246 (01) 214-221
- 3 Lake H, Tomazzoni T, Muzio BD, Gaillard F. Top 10 Helpful Measurements and Scoring System for Neurodegenerative Brain MRI Interpretation. EPOS; 2015: 1-14
- 4 Constantinides VC, Paraskevas GP, Velonakis G, Toulas P, Stamboulis E, Kapaki E. MRI planimetry and Magnetic Resonance Parkinsonism Index in the differential diagnosis of patients with parkinsonism. AJNR Am J Neuroradiol 2018; 39 (06) 1047-1051
- 5 Sankhla CS, Patil KB, Sawant N, Gupta S. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients. Neurol India 2016; 64 (02) 239-245
- 6 Whitwell JL, Höglinger GU, Antonini A. et al; Movement Disorder Society-endorsed PSP Study Group. Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be?. Mov Disord 2017; 32 (07) 955-971
- 7 Aydn E, Eraslan C, Acarer A. et al. The Morphometric Parameters in MRI for Differentiation Progressive Supranuclear Palsy from Parkinson's disease, Multiple System Atrophy and Controls. EPOS; 2017: 1-11
- 8 Zhang K, Liang Z, Wang C, Zhang X, Yu B, Liu X. Diagnostic validity of magnetic resonance parkinsonism index in differentiating patients with progressive supranuclear palsy from patients with Parkinson's disease. Parkinsonism Relat Disord 2019; 66: 176-181
- 9 Nigro S, Morelli M, Arabia G. et al. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?. Parkinsonism Relat Disord 2017; 41: 31-36
- 10 Zanigni S, Calandra-Buonaura G, Manners DN. et al. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease. Neuroimage Clin 2016; 11: 736-742
- 11 Nigro S, Arabia G, Antonini A. et al. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy. Eur Radiol 2017; 27 (06) 2665-2675